AI in Healthcare Regulation: The FDA opened public comment on a new regulatory approach for generative AI-enabled medical devices, proposing a risk framework and “competency assessment” for premarket review. Personalized Cancer Vaccines: Moderna and Merck reported a late-stage win for an mRNA-based personalized vaccine (intismeran) that helped prevent melanoma return and spread. Enterprise AI Rollout: Anthropic’s Ode bought consultancy Casper Studios to help companies deploy Claude inside existing software, signaling faster “implementation” M&A. AI Education Policy: Vietnam starts AI in schools this year, with an ethics-first curriculum; the U.S. also seeks input on changes to childhood vaccine scheduling. Energy & Materials: Hitachi High-Tech and Powrex demonstrated AI-assisted optimization of cathode coating for all-solid-state batteries, aiming to cut lab-to-fab time. Data Centers & Power: Public Citizen urged Texas lawmakers to pause new data centers, tighten air permitting, and end tax breaks tied to qualifying facilities. Semiconductors & Memory: Micron unveiled a $10B U.S. memory research hub in Idaho to accelerate AI chip performance. Trade & Food Supply: U.S. tariff rules continue to reshape wheat trade, with older authorities like Section 232 still affecting the value chain.